Cite
HARVARD Citation
Huang, Y. et al. (2022). PCSK9 inhibition in patients with acute stroke and symptomatic intracranial atherosclerosis: protocol for a prospective, randomised, open-label, blinded end-point trial with vessel-wall MR imaging. BMJ open. 12 (4), p. . [Online].